FDA Medical Device Registration: Step-by-Step Process from Classification to Market

Step-by-step FDA medical device registration — classification, 510(k)/De Novo/PMA pathways, establishment registration, device listing, FY 2026 fees, and post-market obligations.

The Four-Step Framework FDA Expects You to Follow

FDA's own guidance for manufacturers is organized into a four-step sequence: classify your device, select and prepare the correct premarket submission, submit and interact with FDA during review, and comply with applicable regulatory controls including establishment registration and device listing. Each step builds on the previous one, and missing or shortcutting any step causes delays that compound through the entire process.

This guide walks through all four steps with current 2026 requirements, fees, timelines, and the practical decisions that determine how long your path to market actually takes.

Step 1: Classify Your Device and Determine the Regulatory Pathway

How FDA Classifies Medical Devices

FDA places medical devices into three regulatory classes based on the level of control necessary to provide reasonable assurance of safety and effectiveness:

Class	Risk Level	Controls Required	Typical Examples
Class I	Low	General controls	Elastic bandages, manual surgical instruments, examination gloves
Class II	Moderate	General + special controls	Infusion pumps, powered wheelchairs, blood glucose meters, surgical lasers
Class III	High	General controls + PMA	Implantable pacemakers, heart valves, spinal fusion cages

Approximately 47% of device types are Class I, 43% are Class II, and 10% are Class III. Classification is determined by the device's intended use and the risk it poses to patients and users.

Where to Find Your Classification

Three primary resources determine your classification:

FDA Product Classification Database (accessdata.fda.gov) — Search by device name or keyword to find your product code, regulation number (21 CFR Parts 862–892), classification, and whether a 510(k) is required.
Classification regulations in 21 CFR Parts 862–892 — These regulations define each device type and state the class and any applicable exemptions.
513(g) Classification Request — If you cannot determine classification from the database, you can submit a written request to FDA under section 513(g) of the FD&C Act. FDA will respond with the classification and applicable regulatory requirements. The FY 2026 fee for a 513(g) request is $7,820 ($3,910 for small businesses).

Device Types That Do Not Fit Neatly Into One Class

Some product types require additional analysis:

Combination products (drug-device or biologic-device) — Classification is determined by the primary mode of action. FDA's Office of Combination Products assigns jurisdiction.
Software as a Medical Device (SaMD) — Classification follows the same risk framework but may require analysis under FDA's digital health policies and IEC 62304.
Borderline products — Products that could be devices, drugs, cosmetics, or biological products may require a formal Request for Designation (RFD) to FDA's Office of Combination Products.

Determine Your Premarket Pathway

Once classified, your device type maps to a specific premarket pathway:

Pathway	Applies To	Typical Timeline	FY 2026 Fee
510(k) Exempt	Most Class I, some Class II	No premarket submission needed	$0
510(k) (Premarket Notification)	Most Class II, some Class I	90 FDA days (4–9 months calendar)	$26,067 ($6,517 SB)
De Novo	Novel low-to-moderate risk devices with no predicate	150–270 days	$173,782 ($43,446 SB)
PMA (Premarket Approval)	Class III devices	180–365+ days	$579,272 ($144,818 SB)
HDE (Humanitarian Device Exemption)	Devices for diseases affecting ≤8,000 individuals/year in US	Varies	$0 (for first HDE for a humanitarian use device)

The most common pathway is the 510(k). FDA data shows that approximately 3,000–4,000 510(k)s are cleared each year, compared to roughly 30–50 original PMAs.

Small Business Determination

If your company (including affiliates) had gross receipts of $100 million or less during the most recent tax year, you qualify for substantially reduced user fees. For FY 2026:

510(k) small business fee: $6,517 (vs. $26,067 standard)
De Novo small business fee: $43,446 (vs. $173,782 standard)
PMA small business fee: $144,818 (vs. $579,272 standard)

You must obtain a Small Business Determination (SBD) from FDA before submitting your premarket application with the reduced fee. Submit Form FDA 3602N with supporting tax documentation. Processing takes approximately 60 days, so plan accordingly. Starting in FY 2026, FDA may also grant a waiver of the annual establishment registration fee for qualifying small businesses.

Step 2: Prepare and Submit Your Premarket Application

510(k) Submissions

The 510(k) process requires demonstrating that your device is "substantively equivalent" to a legally marketed predicate device. Substantial equivalence means the new device:

Has the same intended use as the predicate, and
Has the same technological characteristics or different technological characteristics that do not raise new safety/effectiveness questions and are as safe and effective as the predicate

Types of 510(k) submissions:

Type	When to Use	Review Target
Traditional 510(k)	New device compared to a predicate; most common pathway	90 FDA days
Special 510(k)	Changes to your own legally marketed device using design controls	30 FDA days
Abbreviated 510(k)	Device conforms to recognized consensus standards or FDA guidance	90 FDA days

Since October 2023, eSTAR (electronic Submission Template And Resource) is the mandatory format for 510(k) submissions to CDRH. eSTAR is a structured PDF form that walks you through all required content sections, reducing Refuse to Accept (RTA) rates.

Key sections of a 510(k):

Device description and comparison to predicate
Substantial equivalence discussion
Proposed labeling and indications for use
Design control documentation (verification and validation)
Non-clinical testing (bench, biocompatibility, EMC, software)
Clinical data (if required by guidance or necessary for equivalence)
Sterilization, shelf life, and packaging information
Software documentation (per IEC 62304 if applicable)

De Novo Classification Requests

The De Novo pathway is for novel devices of low to moderate risk that have no legally marketed predicate. A successful De Novo request creates a new classification regulation and product code, which then serves as a predicate for future 510(k) submissions from any manufacturer.

De Novo requires comprehensive information including device description, non-clinical and clinical evidence, proposed classification and special controls, and labeling. It is more rigorous than a 510(k) but less extensive than a PMA.

PMA Submissions

PMA is the most rigorous pathway, required for Class III devices that support or sustain life, are implanted, or present potential unreasonable risk. A PMA requires:

Comprehensive non-clinical laboratory studies
Clinical investigation data (typically from an IDE study)
Manufacturing information including quality system details
Complete device description and engineering drawings

Step 3: FDA Review and Interaction

510(k) Review Timeline

The 510(k) review process follows a structured timeline under MDUFA V commitments:

Phase	Duration	Activity
Acceptance Review	≤15 calendar days	FDA determines if the submission meets minimum completeness criteria
RTA Hold (if triggered)	Up to 180 calendar days to respond	Submitter must address deficiencies or the 510(k) is withdrawn
Substantive Review	≤60 FDA days	Lead reviewer evaluates technical content
Interactive Review	Concurrent with substantive	FDA may contact submitter for clarifications
Additional Information Request	Stops the clock	Submitter has 180 calendar days to respond
MDUFA Decision	≤90 FDA days total	SE (Substantially Equivalent) or NSE (Not Substantially Equivalent)

Understanding "FDA Days" vs. calendar time: The 90-day goal is measured in "FDA days" — calendar days excluding time the submission is on hold for an Additional Information (AI) request. In practice, most 510(k) submissions take 4–9 months of calendar time from submission to clearance. Data from analyses of approximately 25,000 510(k)s between 2010–2021 showed an average of about 164 FDA days between submission and decision.

Current data indicates traditional 510(k) submissions average 140–175 days for clearance, with 70–80% of submissions exceeding the 90-day target. Well-prepared submissions with complete data and clear predicate comparisons clear faster.

Key Review Communication Points

Day 1: FDA receives the submission and assigns a K-number (e.g., K260001)
By Day 15: Acceptance Review result (accepted or RTA hold)
By Day 60: Substantive Interaction — FDA communicates any concerns
By Day 100: If outstanding issues remain, FDA notifies the submitter
By Day 90 FDA days: MDUFA decision (SE or NSE)

When FDA Requests Additional Information

AI requests are common. FDA data shows the average 510(k) requires approximately 1.58 review cycles, meaning most submissions receive at least one AI request. Your response must be complete and address every deficiency cited. Incomplete responses may result in a second AI request or an NSE decision.

Step 4: Establishment Registration and Device Listing

Who Must Register

Under 21 CFR Part 807, the following establishment types must register with FDA:

Domestic manufacturers of medical devices
Foreign manufacturers exporting devices to the US
Specification developers who develop device specifications (even if manufacturing is outsourced)
Initial importers of foreign-made devices
Repackers and relabelers
Contract sterilizers
Remanufacturers

Each establishment must register independently. A contract manufacturer's registration does not cover the specification developer.

FY 2026 Registration Fee

The annual establishment registration fee for FY 2026 (October 1, 2025 through September 30, 2026) is $11,423. There is no small business reduction for registration fees. Starting in FY 2026, FDA may grant a waiver of the annual registration fee (excluding initial registration) for small businesses that demonstrate financial hardship.

Registration Process

Registration and listing is completed electronically through FDA's FURLS (FDA Unified Registration and Listing System) / DRLM (Device Registration and Listing Module):

Create an FDA account through the FURLS portal
Pay the annual registration fee and obtain a Payment Confirmation Number (PCN). Important: Do not pay before October 1 for renewal — early payments apply to the previous fiscal year.
Submit registration information including facility details, ownership structure, and manufacturing activities
List each device with proprietary names, product codes, regulatory classification, and premarket submission numbers (510(k), De Novo, PMA, etc.)

Critical Timing Rules

Initial registration: Within 30 days of beginning commercial distribution. For foreign establishments, registration must be completed before exporting to the US.
Annual renewal: Between October 1 and December 31 each year, regardless of initial registration date
If your device requires premarket clearance (510(k), De Novo, PMA, HDE): You cannot list the device until FDA has cleared or approved it. You can, however, register your establishment before receiving clearance.

Foreign Establishment Requirements

Foreign establishments have additional obligations:

U.S. Agent designation: Every foreign establishment must designate a single U.S. Agent who serves as the primary FDA contact
Import registration: Foreign establishments must be registered and devices listed before the device may be imported into the United States
Device listing prerequisite: The device must have the appropriate premarket submission number before listing

Post-Market Obligations After Registration

Getting your device registered and listed is not the end of your regulatory obligations. FDA requires ongoing compliance:

Quality System Requirements

Since February 2, 2026, all medical device manufacturers must comply with the Quality Management System Regulation (QMSR), which replaced the former Quality System Regulation (QSR). QMSR incorporates ISO 13485:2016 by reference and adds FDA-specific requirements including requirements related to devices and technology not covered by ISO 13485.

Medical Device Reporting (MDR)

Manufacturers, importers, and device user facilities must report adverse events and malfunctions:

Manufacturers: Report deaths, serious injuries, and malfunctions within 30 calendar days. Report events requiring remedial action within 5 working days.
Importers: Report deaths and serious injuries within 30 days, malfunctions within 30 days
Device user facilities: Report deaths to FDA and the manufacturer within 10 working days; report serious injuries to the manufacturer within 10 working days

UDI Compliance

Most devices must bear a Unique Device Identifier (UDI) on their label and packaging, and UDI records must be submitted to the Global Unique Device Identification Database (GUDID). Requirements are phased by device class:

Class III and life-sustaining/life-supporting devices: September 24, 2015 (direct mark)
Class II devices: September 24, 2016 (labels and packages)
Class I and unclassified devices: September 24, 2018 (labels and packages)

Post-Market Surveillance

Depending on your device class and type, you may be subject to:

Section 522 post-market surveillance studies — FDA can order manufacturers of certain Class II or Class III devices to conduct post-market studies
Post-market performance studies under 21 CFR 822
Annual reports for PMA devices
Post-market surveillance plans for devices under section 519 of the FD&C Act

Common Mistakes That Delay Registration

Misclassification

Using incorrect product codes leads to the wrong regulatory pathway and potential delays. Verify classification through FDA's product classification database and cross-reference with the classification regulation.

Premature Registration

You cannot register a device requiring premarket clearance until FDA has made a decision. Registering before clearance is a common compliance error that can trigger FDA enforcement action.

Missing the Annual Renewal Window

Manufacturing or distributing after December 31 without completing annual registration means your establishment is not duly registered and your devices are considered misbranded under the FD&C Act.

Incomplete Device Listings

Missing proprietary names, incorrect submission numbers, or incomplete activity descriptions trigger FDA review delays. Each device must be listed individually with all required information.

Assuming Contract Manufacturer Registration Covers You

Each establishment registers independently based on its own role. If you are a specification developer, you must register even if your contract manufacturer is already registered. Your registration covers your activities; theirs covers theirs.

FDA Registration Fees: FY 2026 Summary

Fee Category	Standard Fee	Small Business Fee
Annual Establishment Registration	$11,423	$11,423 (no reduction)
510(k)	$26,067	$6,517
De Novo Classification Request	$173,782	$43,446
PMA, PDP, PMR, BLA	$579,272	$144,818
513(g) Classification Request	$7,820	$3,910
Panel-Track Supplement	$463,418	$115,855
180-Day Supplement	$86,891	$21,723

Source: FDA MDUFA Fees for FY 2026, effective October 1, 2025.

Key Takeaways

Start with classification. Everything flows from your device's classification — fees, pathway, timeline, and post-market obligations. Use FDA's product classification database as your first step.
Budget 4–9 months for a 510(k). The official target is 90 FDA days, but AI requests, RTA holds, and reviewer interactions extend calendar time significantly.
Establishment registration and device listing are separate from premarket clearance. You can submit a 510(k) before registering your establishment, but you must complete registration and listing before commercially distributing your device.
QMSR compliance is now mandatory. Since February 2, 2026, FDA expects ISO 13485-aligned quality management systems. Factor this into your regulatory planning.
Annual renewal is non-negotiable. Missing the October 1–December 31 registration renewal window means your devices are misbranded and your establishment is not in compliance.

Sources

FDA, "How to Study and Market Your Device," updated January 30, 2026
FDA, "Device Registration and Listing," current as of 2026
FDA, "510(k) Submission Process," current as of 2026
FDA, "CDRH Proposed Guidances for Fiscal Year 2026 (FY2026)"
FDA, "Medical Device User Fee Amendments (MDUFA): Fees," FY 2026
Federal Register, "Medical Devices; Exemptions From Premarket Notification: Certain Class II Devices; Request for Comments," May 1, 2026 (Docket No. FDA-2026-N-4268)
Emergo by UL, "US FDA Expectations Overview," March 13, 2026
The FDA Group, "FDA 510(k) Explained: A Basic Guide to Premarket Notification," November 19, 2025
Complizen, "How to Register Your Medical Device Company with FDA," 2026
Complizen, "FDA Device Registration and Listing Guide," 2025
MD+DI, "Factors Influencing FDA Clearance Time for Medical Devices," 2025